Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
130005 trials found · Page 3539 of 6501
-
Autism gene hunt: blood test may reveal hidden causes
Diagnosis CompletedEvaluation of the diagnostic performance of exome sequencing in a prospective series of patients with autism spectrum disorders (ASD).
Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThe primary objective of this trial is: Part I * To determine Maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of BI 836880 monotherapy Part II * To determine MTD and/or RP2D of the combination therapy of BI 836880 and BI 754091 The secondary objectives are:…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis phase I trial studies the side effects and best dose of a modified virus called VSV-IFNbetaTYRP1 in treating patients with stage III-IV melanoma. The vesicular stomatitis virus (VSV) has been altered to include two extra genes: human interferon beta (hIFNbeta), which may pro…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo targets Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this study is to test the safety and preliminary efficacy of olaparib and vorinostat when used together in participants with relapsed/refractory and or metastatic breast cancer.
Phase 1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New PET tracer aims to spot prostate cancer more clearly
Diagnosis CompletedA Phase 1, Open-label Study to Assess Safety, Biodistribution, and Internal Radiation Dosimetry of rhPSMA-7.3 (18F) Injection in Healthy Volunteers, and to Assess Safety and Investigate the Imaging Characteristics in Subjects With Prostate Cancer.
Phase 1 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New study aims to personalize throat cancer treatment using genetic tests and MRI
Knowledge-focused OngoingThis prospective interventional study evaluates the predictive value of tumor mutational burden, liquid biopsy biomarkers (including circulating tumor DNA), angiogenic factors, and dynamic contrast-enhanced magnetic resonance (MR) perfusion imaging in patients with HPV-negative o…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
AI analyzes heart scans to predict heart attacks
Knowledge-focused OngoingThe goal of this observational study is to learn whether combining stress echocardiography (stress echo) results with routine clinical information can better predict important heart outcomes in adults (18+) with chest pain who were assessed for suspected coronary artery disease. …
Sponsor: Milton Keynes University Hospital NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can an iPad app boost brain power after tumor treatment?
Symptom relief Recruiting nowPatients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation, and chemotherapy, often lead to impaired attention, working memory, and other cognitive functions. These cognitive defi…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Fewer biopsy cores may be safer and just as accurate for prostate cancer detection
Diagnosis Stopped earlyThis is a multicentre, paired-cohort, prospective, controlled study. The patient with a suspicion of PCa and a concomitant positive mpMRI (defined as presence of one lesion PI-RADS ≥ 3) will receive a MRI-TBx (4 target cores). During the same session, subsequently to MRI-TBx, pat…
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New drug shows promise for fatty liver – but early days
Disease control CompletedDouble-blind, randomized, placebo-controlled study to explore the efficacy and safety of elobixibat compared to placebo in adults with NAFLD (nonalcoholic fatty liver disease) or NASH (nonalcoholic steatohepatitis)
Phase 2 • Sponsor: Albireo • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for MDS patients? study tests MBG453 combo but ends early
Disease control Stopped earlyThis Phase II was a multicenter, randomized, two-arm parallel-group, double-blind, placebo-controlled study of MBG453 or placebo added to hypomethylating agents (azacitidine or decitabine) in adult subjects with IPSS-R intermediate, high or very high risk myelodysplastic syndrome…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study: walking may ease crushing fatigue after lung cancer surgery
Symptom relief CompletedAmong 13 core symptoms across 3,106 breast, colorectal, prostate, and lung cancer patients, persons with lung cancer were the most symptomatic, with moderate to severe fatigue being reported with the greatest prevalence. This is a proposed randomized controlled trial of a novel r…
Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can numbing cream boost recovery after spinal injury?
Symptom relief CompletedThe investigators are conducting a research study to try to improve rehabilitation interventions for individuals with spinal cord injury (SCI). In this study, the aim is to determine if temporarily numbing non-paralyzed arm muscles with an over-the-counter numbing cream while exe…
Phase 1 • Sponsor: University of Texas Rio Grande Valley • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could a zapping cap ease autism symptoms? new trial tests brain stimulation in kids
Symptom relief Recruiting nowThe purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThe purpose of this study is to assess the safety, tolerability, pharmacokinetic and pharmacodynamic properties of APG-2575 in patients with relapse or refractory chronic lymphocytic leukemia and non-hodgkin's lymphoma.
Phase 1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a sleep drug help people with PSP rest better?
Symptom relief CompletedPrior research has identified profound sleep disruption in individuals with PSP. Not only were these individuals sleeping relatively short periods at night, they were also not recuperating lost sleep during the day. Research also showed the relative preservation of a series of nu…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New study finds best way to help spinal cord injury patients lose weight
Disease control CompletedThis study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the…
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can we fix toxic surgery training? national trial tests new strategies
Knowledge-focused CompletedDue to a number of factors, residents are susceptible to mistreatment (i.e., discrimination, harassment, and abuse) and toxic outcomes (i.e., burnout, attrition, and suicidality). Our work following the FIRST Trial identified considerable variation in program-level rates of resid…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Brain scans reveal why dieting fails?
Knowledge-focused CompletedPatients and clinicians need better options to prevent the weight regain that almost universally follows a weight loss intervention. In lay terms, a new, higher "set point" seems to occur after people gain weight. Evidence from some research studies reinforces these observations,…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:45 UTC
-
Yoga may ease cancer treatment side effects for patients and partners
Symptom relief OngoingThis clinical trial seeks to learn if a yoga program can improve physical performance, quality of life and symptom burden in cancer patients who are undergoing radiation therapy, and their partners. Taking part in yoga or stretching sessions may lower distress, improve quality of…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC